Cresilon, Inc. filed a Form D with the Securities and Exchange Commission on 2025-12-08.
Cresilon, Inc. filed a Form D notice of an exempt securities offering with the SEC on December 8, 2025. The filing reports $6.68M sold. Its industry group is Biotechnology. It names Joseph Landolina (Executive Officer, Director), Isaac Miller (Executive Officer, Director), Scott Levine (Executive Officer) (SEC Form D, December 8, 2025).
Is this your company?
Sell to companies like Cresilon, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-12-08 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Cresilon, Inc.
Free to see. No signup.
More on the people and the money behind Cresilon, Inc., from the filings we hold.
Paulson Investment Company, LLC received sales compensation on this raise and on 4 other raises we hold, nearest in date first:
Biotechnology raises by companies based in New York, filed in December 2025, largest first.
Get an email when Cresilon, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Cresilon, Inc. raises, hires or launches. No email unless you switch it on.
Watch Cresilon, Inc. →Get the full cited report on Cresilon, Inc.
What the filing shows about Cresilon, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Cresilon, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Cresilon, Inc.'s address as 86 34th St., Suite 6-3-D, Brooklyn, NY 11232.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Cresilon, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Cresilon, Inc. is a registered filer with the SEC (CIK 1728054) and has filed since 2022-10-18. 6 filings are on record, the latest on 2026-04-29.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Cresilon, Inc.'s Form D of 2025-12-08 names Joseph Landolina, Isaac Miller and Scott Levine as its officers, directors or promoters.
Its new offerings report $96.09M sold across 6 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 759 filings in Biotechnology, totalled by week. The dot is this raise, $6.68M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Joseph Landolina is named as Executive Officer and Director on the Form D that Cresilon, Inc. filed with the SEC on 8 December 2025, one of 3 people that filing names.
Isaac Miller is named as Executive Officer and Director on the Form D that Cresilon, Inc. filed with the SEC on 8 December 2025, one of 3 people that filing names.
Scott Levine is named as Executive Officer on the Form D that Cresilon, Inc. filed with the SEC on 8 December 2025, one of 3 people that filing names.
3 people named on the filing — 3 holding an executive role.
Named as of the 2025-12-08 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Cresilon, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Cresilon, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Cresilon, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Cresilon, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Cresilon, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Cresilon, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in New York
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/cresilon-inc-form-d-25000001